noom glp 1 companion GLP-1 Noom GLP-1 Access and Transparency

Therefore, the development of novel drug delivery systemswhether by enhancing BRB penetration or through direct ocular targeting (e.g., long-acting intravitreal formulations)is a critical and rate-limiting step for the clinical translation of these agents

Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Key takeaways about GLP-1 hair loss: Hair loss from GLP-1 receptor agonists is typically caused by rapid weight loss, not the medication itself, and is a temporary condition called telogen effluvium

All human evidence consists of case reports and anecdotal experience